Headline
The latest stories from AHA Today.
The Department of Health and Human Services announced that it will partner with the Department of Defense to fund the advanced development — including clinical trials and large-scale manufacturing — of a COVID-19 investigational vaccine from Sanofi and GlaxoSmithKline.
The AHA, the American Medical Association and American Nurses Association partnered to release a public service announcement urging the American public to take three simple steps to help stop the spread of COVID-19: wear a mask, practice physical distancing and wash hands frequently.
In this new Hospitals Against Violence resource, Melinda Hatton, AHA general counsel and HAV executive sponsor, interviews Hanni Stoklasa, M.D., emergency medicine physician at Brigham and Women’s Hospital and executive director of HEAL Trafficking, to discuss the state of anti-trafficking efforts…
The Centers for Medicare & Medicaid Services announced that for 2021 the average basic premium for Medicare Part D prescription drug plans will be $30.50.
The Department of Health and Human Services released a report on surprise medical billing that summarizes research on the prevalence of these bills and recent federal and state actions to prevent them.
AHA Board Chair Melinda Estes, M.D., authored an opinion article for USA Today, urging patients to continue to rely on hospitals and emergency rooms for non-COVID-19, life-saving, medically necessary care.
Nearly 44% of primary care visits for Medicare fee-for-service beneficiaries were telehealth visits in April, up from 0.1% in February, according to a report released by the Department of Health and Human Services.
AHA released The Future of Telehealth — Protecting Patient Access to Care, which urges Congress and the Administration to ensure telehealth flexibilities remain in place after the COVID-19 public health emergency and to reimburse virtual services on par with in-person care.
A federal judge in New York prevented the Department of Homeland Security from continuing to implement its public charge rule during the COVID-19 public health emergency and issued a nationwide injunction.
The Centers for Medicare & Medicaid Services added 12 new ICD-10 procedure codes to identify new therapies for COVID-19.